abstract |
The application provides compounds of the following formula (I) and their enantiomers and pharmaceutically acceptable salts and esters, wherein X, Y, Z, R 1 , R 2 , R 3 and R 4 are as described in the application and methods of preparing said compounds, pharmaceutical compositions comprising said compounds and their use in the treatment of cancer. |